Mucocutaneous Epithelial Cell Growth Factor [EPC]

389 reported adverse events

Drugs of this class: PALIFERMIN

These side effects are most commonly reported by patients taking drugs of the Mucocutaneous Epithelial Cell Growth Factor [EPC] class:

# Side effect Count
0 MUCOSAL INFLAMMATION 56
1 FEBRILE NEUTROPENIA 39
2 RASH 39
3 STOMATITIS 34
4 ERYTHEMA 28
5 SEPSIS 24
6 PYREXIA 23
7 NEUTROPENIA 21
8 DIARRHOEA 20
9 INFECTION 19
See all common reactions for Mucocutaneous Epithelial Cell Growth Factor [EPC]

Drugs of the Mucocutaneous Epithelial Cell Growth Factor [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 GUM NEOPLASM MALIGNANT STAGE UNSPECIFIED 1 0.1667
1 PARAESTHESIA OF GENITAL FEMALE 1 0.0714
2 FUNGUS CULTURE POSITIVE 1 0.0476
3 HYPERCHROMASIA 1 0.0435
4 NECROTISING GASTRITIS 1 0.0312
5 MYOCARDITIS BACTERIAL 1 0.0303
6 B-CELL LYMPHOMA STAGE III 1 0.0263
7 ANALGESIC DRUG LEVEL DECREASED 1 0.0227
8 COLON POLYPECTOMY 1 0.0185
9 MUCOSAL MEMBRANE HYPERPLASIA 1 0.0182
See all enriched reactions for Mucocutaneous Epithelial Cell Growth Factor [EPC]